Registered entities
Rgenta Therapeutics, Inc.,
Reg. No. 82-5268874United States
Social engagement
Social engagement: 6.5K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Matrix Partners China, AstraZeneca.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 46% |
| Private equity | 3 | 23% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 3 | 23% |
Recent activity
22 Jun 2026
Event
Evercore Private Company Conference
14 May 2026
Event
BiotechTV
11 May 2026
Event
ASGCT 2026